Craig Okada
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Oncology top 5%
- CAR-T cell therapy research
Papers in
- Genetics 16
- Chronic Lymphocytic Leukemia Research 14
- Immunology 27
- Immune Cell Function and Interaction 14
- Immunotherapy and Immune Responses 13
- T-cell and B-cell Immunology 8
- Co-authors
- Martin RechsteinerIrving L. WeissmanRonald LevyEdgar G. EnglemanClaudia BenikeChristoph MuellerVolker L. ReichardtKeith Stockerl‐Goldstein
- Journals
- Blood (12 papers)The Journal of Immunology (5 papers)Journal of Clinical Oncology (3 papers)The Journal of Experimental Medicine (2 papers)Blood Advances (2 papers)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Craig Okada
48 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 94
- Immunology 1.7k
- Oncology 749
- Pathology and Forensic Medicine 460
- Genetics 249
- Radiology, Nuclear Medicine and Imaging 407
Countries citing papers authored by Craig Okada
This map shows the geographic impact of Craig Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Okada more than expected).
Fields of papers citing papers by Craig Okada
This network shows the impact of papers produced by Craig Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Okada. The network helps show where Craig Okada may publish in the future.
Co-authors
The 25 scholars most cited alongside Craig Okada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 16 | |
| 4 | 2021 | 12 | |
| 5 | 2019 | 40 | |
| 6 | 2018 | 6 | |
| 7 | 2011 | 31 | |
| 8 | A Phase Ii International, Multicenter Study of Oral Panobinostat (lbh589) in Patients With Refractory Cutaneous T-cell Lymphoma (ctcl) | 2008 | 1 |
| 9 | 2005 | 1 | |
| 10 | 2004 | 19 | |
| 11 | 2004 | 11 | |
| 12 | 2002 | 44 | |
| 13 | 2001 | 11 | |
| 14 | 1999 | 34 | |
| 15 | T cell antigen receptor vaccines for active immunotherapy of T cell malignancies | 1998 | 1 |
| 16 | Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma. | 1997 | 23 |
| 17 | 1997 | 37 | |
| 18 | 1990 | 112 | |
| 19 | 1989 | 57 | |
| 20 | 1988 | 119 |
About Craig Okada
Craig Okada is a scholar working on Genetics, Immunology, Pathology and Forensic Medicine, Oncology and Dermatology, having authored 49 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (14 papers), Immune Cell Function and Interaction (14 papers), CAR-T cell therapy research (13 papers), Immunotherapy and Immune Responses (13 papers), T-cell and B-cell Immunology (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Viral-associated cancers and disorders (6 papers). The work is most often cited by research in Immunology (1.7k citations), Oncology (749 citations), Pathology and Forensic Medicine (460 citations), Genetics (249 citations) and Radiology, Nuclear Medicine and Imaging (407 citations). Craig Okada has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Martin Rechsteiner, Irving L. Weissman, Ronald Levy, Edgar G. Engleman, Claudia Benike, Christoph Mueller, Volker L. Reichardt, Keith Stockerl‐Goldstein, Karl G. Blume and Arcangelo Liso. Their work appears in journals such as Blood, The Journal of Immunology, Journal of Clinical Oncology, The Journal of Experimental Medicine and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.